Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

Fatty liver, insulin resistance, and dyslipidemia.

Adiels M, Taskinen MR, Borén J.

Curr Diab Rep. 2008 Feb;8(1):60-4. Review.

PMID:
18367000
[PubMed - indexed for MEDLINE]
2.

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.

Adiels M, Olofsson SO, Taskinen MR, Borén J.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1225-36. doi: 10.1161/ATVBAHA.107.160192. Review.

PMID:
18565848
[PubMed - indexed for MEDLINE]
Free Article
3.

Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance.

Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF.

Trends Cardiovasc Med. 2001 Jul;11(5):170-6. Review.

PMID:
11597827
[PubMed - indexed for MEDLINE]
4.

[Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].

Lazebnik LB, Zvenigorodskaia LA, Egorova EG, Mel'nikova NV, Khomeriki SG.

Eksp Klin Gastroenterol. 2009;(8):4-11. Russian.

PMID:
20469672
[PubMed - indexed for MEDLINE]
5.

Lipid and lipoprotein dysregulation in insulin resistant states.

Avramoglu RK, Basciano H, Adeli K.

Clin Chim Acta. 2006 Jun;368(1-2):1-19. Epub 2006 Feb 9. Review.

PMID:
16480697
[PubMed - indexed for MEDLINE]
6.

Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.

Yki-Järvinen H.

Dig Dis. 2010;28(1):203-9. doi: 10.1159/000282087. Epub 2010 May 7. Review.

PMID:
20460912
[PubMed - indexed for MEDLINE]
7.

Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.

Cohen DE, Fisher EA.

Semin Liver Dis. 2013 Nov;33(4):380-8. doi: 10.1055/s-0033-1358519. Epub 2013 Nov 12. Review.

PMID:
24222095
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion.

Avramoglu RK, Qiu W, Adeli K.

Front Biosci. 2003 Jan 1;8:d464-76. Review.

PMID:
12456312
[PubMed - indexed for MEDLINE]
9.

Type 2 diabetes as a lipid disorder.

Taskinen MR.

Curr Mol Med. 2005 May;5(3):297-308. Review.

PMID:
15892649
[PubMed - indexed for MEDLINE]
10.

[Atherogenic dyslipidemia and the metabolic syndrome: pathophysiological mechanisms].

Zák A, Slabý A.

Cas Lek Cesk. 2008;147(9):459-70. Review. Czech.

PMID:
18988488
[PubMed - indexed for MEDLINE]
11.

Dyslipidemia in patients with nonalcoholic fatty liver disease.

Chatrath H, Vuppalanchi R, Chalasani N.

Semin Liver Dis. 2012 Feb;32(1):22-9. doi: 10.1055/s-0032-1306423. Epub 2012 Mar 13. Review.

PMID:
22418885
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.

Parekh S, Anania FA.

Gastroenterology. 2007 May;132(6):2191-207. Review.

PMID:
17498512
[PubMed - indexed for MEDLINE]
14.

[Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].

Zheng LY, Pan JQ, Lv JH.

Zhongguo Zhong Yao Za Zhi. 2008 Oct;33(20):2385-90. Chinese.

PMID:
19157135
[PubMed - indexed for MEDLINE]
15.

Diabetic dyslipidaemia.

Adiels M, Olofsson SO, Taskinen MR, Borén J.

Curr Opin Lipidol. 2006 Jun;17(3):238-46. Review.

PMID:
16680028
[PubMed - indexed for MEDLINE]
16.

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.

Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J.

Diabetologia. 2007 Nov;50(11):2356-65. Epub 2007 Sep 12.

PMID:
17849096
[PubMed - indexed for MEDLINE]
17.

Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance.

Savage DB, Semple RK.

Curr Opin Lipidol. 2010 Aug;21(4):329-36. doi: 10.1097/MOL.0b013e32833b7782. Review.

PMID:
20581678
[PubMed - indexed for MEDLINE]
18.

Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise.

Lavoie JM, Gauthier MS.

Cell Mol Life Sci. 2006 Jun;63(12):1393-409. Review.

PMID:
16649140
[PubMed - indexed for MEDLINE]
20.

Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.

Chan DC, Barrett PH, Watts GF.

Clin Sci (Lond). 2004 Sep;107(3):233-49. Review.

PMID:
15225143
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk